CME Trade Plan Analysis


#MyGateTradeStory
Current Snapshot
Price: $252.51 (-3.46%) — heavy sell day
Pre-Market: $254.30 (+0.70%) — minor bounce attempt
Previous Close: $261.56 — gapped down hard at open
Timeframe: 1H chart
Technical Indicators
Bollinger Bands (20,2)
Upper: $272.16 | Mid: $258.37 | Lower: $244.57
Price is below the midband and falling fast
Bands are expanding aggressively downward — momentum breakdown
Next major support: lower BB at $244.57
SuperTrend (10,3): $259.11
Price is well below SuperTrend — bearish ❌
SuperTrend flipped and is now acting as overhead resistance
The sharp candle drop from $270 area is a classic SuperTrend breakdown
MACD
MACD: -0.99 | DIF: -3.56 | DEA: -2.57
DIF is well below DEA and both negative — strong bearish momentum
Histogram expanding negatively — selling pressure increasing, no floor yet
Chart Pattern
Textbook distribution top followed by sharp breakdown:
Consolidated near $270 for several days
Sharp rejection and breakdown through all support levels
Today's low $246.25 — testing critical zone before lower BB
Trade Plan

Long (Buy)
Short (Sell)
Entry
Confirmed bounce + reclaim of $258 midband
Failed rally at $258–259 (midband/SuperTrend)
Target
$258–259 midband
$246–244 lower BB
Stop Loss
$249
$261
R:R
~1:1.5
~1:2
Bias: Strongly Bearish — Worst Setup of All 5 Stocks
Full updated comparison:
Signal
JPM
CAT
GOOG
NFLX
CME
Above SuperTrend





Above BB Midband





MACD Positive
⚠️
⚠️



Day Performance
+0.71%
+1.06%
-2.43%
-2.26%
-3.46% 💀
Pre-Market
+0.54%
+1.87%
+0.19%
+0.41%
+0.70%
CME is the weakest chart across all 5. The -3.46% day move with a gap down from $261.56, combined with negative MACD divergence and price below all key levels, makes this a short-only or avoid situation.
Only consider a long if price reclaims and holds $258 with strong volume confirmation. Until then, any bounce toward $258–259 is a shorting opportunity targeting $244–246.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned